Sara Lonardi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 61

Top Topics

Metastatic Colorectal Cancer

Locally Advanced

Top Venues

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto Moretto, Daniele Rossini, Aurélie Catteau, Carlotta Antoniotti, Mirella Giordano, Alessandra Boccaccino, Clara Ugolini, Agnese Proietti, Veronica Conca, Alboukadel Kassambara, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Emiliano Tamburini, Anello Marcello Poma, Jacques Fieschi, Gabriella Fontanini, Gianluca Masi, Jérôme Galon, Chiara Cremolini
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study. Journal for immunotherapy of cancer 11 (4) (2023)
Vincenzo Nasca, Francesco Barretta, Francesca Corti, Sara Lonardi, Monica Niger, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Chiara Cremolini, Javier Ros, Margherita Ambrosini, Giacomo Mazzoli, Rossana Intini, Michael J Overman, Rosalba Miceli, Filippo Pietrantonio
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Roberto Moretto, Marco Maria Germani, Javier Ros, Francesca Daniel, Filippo Ghelardi, Guglielmo Vetere, Mirella Giordano, Rodrigo De Almeida Toledo, Francesca Bergamo, Giovanni Randon, Elena Elez, Sara Lonardi, Filippo Pietrantonio, Paola Vignali, Daniele Rossini, Judit Matito, Clara Ugolini, Gabriella Fontanini, Gianluca Masi, Chiara Cremolini
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E -Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy. JCO precision oncology 7 (2023)
Letizia Procaccio, Valeria Merz, Morena Fasano, Vanja Vaccaro, Elisa Giommoni, Andrea Pretta, Silvia Noventa, Maria Antonietta Satolli, Guido Giordano, Clizia Zichi, Carmine Pinto, Camilla Zecchetto, Giulia Barsotti, Ferdinando De Vita, Michele Milella, Lorenzo Antonuzzo, Mario Scartozzi, Alberto Zaniboni, Rosella Spadi, Simona Casalino, Francesca Bergamo, Chiara De Toni, Davide Melisi, Sara Lonardi
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma. Cancer medicine (2023)
Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez Fernandez, Federico Nichetti, Filippo Ghelardi, Vincenzo Nasca, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani, Michele Prisciandaro, Alessandra Raimondi, Alexa B Schrock, Luca Agnelli, Henry S Walch, Takayuki Yoshino, Filippo Pietrantonio
Negative hyper-selection of patients with HER2-positive and RAS wild-type metastatic colorectal cancer receiving dual HER2 blockade: the PRESSING-HER2 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Claire Gallois, Matteo Landi, Gilles Manceau, Marine Sroussi, Bahar Saberzadeh-Ardestani, Antoine Cazelles, Sara Lonardi, Francesca Bergamo, Rossana Intini, Giulia Maddalena, Filippo Pietrantonio, Francesca Corti, Margherita Ambrosini, Antonia Martinetti, Marco Maria Germani, Chiara Boccaccio, Guglielmo Vetere, Sophie Mouillet-Richard, Aurélien de Reyniès, Frank A Sinicrope, Chiara Cremolini, Pierre Laurent-Puig
Transcriptomic Signatures of MSI-high Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Roberto Moretto, Marco Maria Germani, Mirella Giordano, Veronica Conca, Agnese Proietti, Cristina Niccoli, Filippo Pietrantonio, Sara Lonardi, Emiliano Tamburini, Alberto Zaniboni, Alessandro Passardi, Tiziana Pia Latiano, Valentina Fanotto, Samantha Di Donato, Michele Prisciandaro, Francesca Bergamo, Gianluca Masi, Gabriella Fontanini, Clara Ugolini, Chiara Cremolini
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development. British journal of cancer (2023)
Roberto Moretto, Daniele Rossini, Aurélie Catteau, Carlotta Antoniotti, Mirella Giordano, Alessandra Boccaccino, Clara Ugolini, Agnese Proietti, Veronica Conca, Alboukadel Kassambara, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Emiliano Tamburini, Anello Marcello Poma, Jacques Fieschi, Gabriella Fontanini, Gianluca Masi, Jérôme Galon, Chiara Cremolini
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study. Journal for immunotherapy of cancer 11 (4) (2023)
Roberto Moretto, Daniele Rossini, Aurélie Catteau, Carlotta Antoniotti, Mirella Giordano, Alessandra Boccaccino, Clara Ugolini, Agnese Proietti, Veronica Conca, Alboukadel Kassambara, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Emiliano Tamburini, Anello Marcello Poma, Jacques Fieschi, Gabriella Fontanini, Gianluca Masi, Jérôme Galon, Chiara Cremolini
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study. Journal for immunotherapy of cancer 11 (4) (2023)
Ottavia De Simoni, Luca Dal Santo, Melania Scarpa, Giada Munari, Ylenia Camilla Spolverato, Antonio Scapinello, Sara Lonardi, Caterina Soldà, Francesca Bergamo, Alberto Fantin, Romeo Bardini, Pierluigi Pilati, Angelo Paolo Dei Tos, Mario Gruppo
Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis? Current oncology (Toronto, Ont.) 30 (6) (2023)
Roberto Moretto, Marco Maria Germani, Mirella Giordano, Veronica Conca, Agnese Proietti, Cristina Niccoli, Filippo Pietrantonio, Sara Lonardi, Emiliano Tamburini, Alberto Zaniboni, Alessandro Passardi, Tiziana Pia Latiano, Valentina Fanotto, Samantha Di Donato, Michele Prisciandaro, Francesca Bergamo, Gianluca Masi, Gabriella Fontanini, Clara Ugolini, Chiara Cremolini
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development. British journal of cancer (2023)
Giovanni Randon, Yu Aoki, Romain Cohen, Leonardo Provenzano, Vincenzo Nasca, Samuel J Klempner, Steven B Maron, Riccardo Cerantola, Joseph Chao, Lorenzo Fornaro, Walter Ferrari Bravo, Filippo Ghelardi, Margherita Ambrosini, Paolo Manca, Massimiliano Salati, Akihito Kawazoe, Valerie Zhu, Darren Cowzer, Virginia Genovesi, Sara Lonardi, Kohei Shitara, Thierry André, Filippo Pietrantonio
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade. Journal for immunotherapy of cancer 11 (6) (2023)
Ottavia De Simoni, Luca Dal Santo, Melania Scarpa, Giada Munari, Ylenia Camilla Spolverato, Antonio Scapinello, Sara Lonardi, Caterina Soldà, Francesca Bergamo, Alberto Fantin, Romeo Bardini, Pierluigi Pilati, Angelo Paolo Dei Tos, Mario Gruppo
Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis? Current oncology (Toronto, Ont.) 30 (6) (2023)
Vincenzo Nasca, Francesco Barretta, Francesca Corti, Sara Lonardi, Monica Niger, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Chiara Cremolini, Javier Ros, Margherita Ambrosini, Giacomo Mazzoli, Rossana Intini, Michael J Overman, Rosalba Miceli, Filippo Pietrantonio
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Roberto Moretto, Daniele Rossini, Aurélie Catteau, Carlotta Antoniotti, Mirella Giordano, Alessandra Boccaccino, Clara Ugolini, Agnese Proietti, Veronica Conca, Alboukadel Kassambara, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Emiliano Tamburini, Anello Marcello Poma, Jacques Fieschi, Gabriella Fontanini, Gianluca Masi, Jérôme Galon, Chiara Cremolini
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study. Journal for immunotherapy of cancer 11 (4) (2023)
Roberto Moretto, Marco Maria Germani, Mirella Giordano, Veronica Conca, Agnese Proietti, Cristina Niccoli, Filippo Pietrantonio, Sara Lonardi, Emiliano Tamburini, Alberto Zaniboni, Alessandro Passardi, Tiziana Pia Latiano, Valentina Fanotto, Samantha Di Donato, Michele Prisciandaro, Francesca Bergamo, Gianluca Masi, Gabriella Fontanini, Clara Ugolini, Chiara Cremolini
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development. British journal of cancer (2023)
Roberto Moretto, Daniele Rossini, Aurélie Catteau, Carlotta Antoniotti, Mirella Giordano, Alessandra Boccaccino, Clara Ugolini, Agnese Proietti, Veronica Conca, Alboukadel Kassambara, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Emiliano Tamburini, Anello Marcello Poma, Jacques Fieschi, Gabriella Fontanini, Gianluca Masi, Jérôme Galon, Chiara Cremolini
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study. Journal for immunotherapy of cancer 11 (4) (2023)
Tin-Yun Tang, Federico Nichetti, Benjamin Kaplan, Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Caterina Vivaldi, Lorenza Rimassa, Filippo G De Braud, Mario Domenico Rizzato, Dean C Pavlick, Randy Chu, Anaemy Danner De Armas, Radwa Sharaf, Ethan S Sokol, Jordi Rodon Ahnert, Jeffery S Ross, Milind M Javle, Monica Niger
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vincenzo Nasca, Francesco Barretta, Francesca Corti, Sara Lonardi, Monica Niger, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Chiara Cremolini, Javier Ros, Margherita Ambrosini, Giacomo Mazzoli, Rossana Intini, Michael J Overman, Rosalba Miceli, Filippo Pietrantonio
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Ottavia De Simoni, Luca Dal Santo, Melania Scarpa, Giada Munari, Ylenia Camilla Spolverato, Antonio Scapinello, Sara Lonardi, Caterina Soldà, Francesca Bergamo, Alberto Fantin, Romeo Bardini, Pierluigi Pilati, Angelo Paolo Dei Tos, Mario Gruppo
Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis? Current oncology (Toronto, Ont.) 30 (6) (2023)
Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro, Daniele Rossini, Vincenzo Formica, Mario Scartozzi, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Nicoletta Pella, Francesca Bergamo, Alessandra Raimondi, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Cristina Granetto, Fable Zustovich, Monica Ronzoni, Silvana Leo, Federica Morano, Fotios Loupakis, Federica Buggin, Vittorina Zagonel, Angelo Paolo Dei Tos, Chiara Cremolini, Luca Boni, Filippo Pietrantonio, null null
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by GONO Foundation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, Jean-Phillippe Metges, Sara Lonardi, David H Ilson, Nicola Fazio, Tae-Yong Kim, Li-Yuan Bai, Diarmuid Moran, Jianning Yang, Ahsan Arozullah, Jung Wook Park, Jeffrey J Raizer, Yung-Jue Bang, Manish A Shah
ILUSTRO: Phase 2 Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ottavia De Simoni, Luca Dal Santo, Melania Scarpa, Giada Munari, Ylenia Camilla Spolverato, Antonio Scapinello, Sara Lonardi, Caterina Soldà, Francesca Bergamo, Alberto Fantin, Romeo Bardini, Pierluigi Pilati, Angelo Paolo Dei Tos, Mario Gruppo
Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis? Current oncology (Toronto, Ont.) 30 (6) (2023)
Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy J Iveson, Steven R Alberts, Aimery deGramont, Alberto F Sobrero, Daniel G Haller, Eiji Oki, Anthony Frank Shields, Richard M Goldberg, Rachel Kerr, Sara Lonardi, Greg Yothers, Caroline Kelly, Ioannis Boukovinas, Roberto Labianca, Frank A Sinicrope, Ioannis Souglakos, Takayuki Yoshino, Jeffrey A Meyerhardt, Thierry André, Demetris Papamichael, Gilles Manceau
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Daniele Rossini, Carlotta Antoniotti, Sara Lonardi, Filippo Pietrantonio, Roberto Moretto, Lorenzo Antonuzzo, Alessandra Boccaccino, Federica Morano, Marco Brugia, Carmelo Pozzo, Federica Marmorino, Francesca Bergamo, Emiliano Tamburini, Alessandro Passardi, Giovanni Randon, Sabina Murgioni, Beatrice Borelli, Angela Buonadonna, Mirella Giordano, Gabriella Fontanini, Veronica Conca, Vincenzo Formica, Massimo Aglietta, Roberto Bordonaro, Giuseppe Aprile, Gianluca Masi, Luca Boni, Chiara Cremolini
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Alessandra Anna Prete, Letizia Procaccio, Francesca Bergamo, Cosimo Rasola, Floriana Nappo, Vittorina Zagonel, Sara Lonardi
An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 29 (2) (2022)
Giovanni Fucà, Alessandra Raimondi, Michele Prisciandaro, Sara Lonardi, Chiara Cremolini, Margherita Ratti, Matteo Clavarezza, Roberto Murialdo, Andrea Sartore-Bianchi, Valeria Smiroldo, Rosa Berenato, Patrizia Racca, Francesca Bergamo, Salvatore Corallo, Maria Di Bartolomeo, Filippo G De Braud, Federica Morano, Filippo Pietrantonio
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study. The oncologist 27 (1) (2022)
Giampaolo Bianchini, Grazia Arpino, Laura Biganzoli, Sara Lonardi, Fabio Puglisi, Daniele Santini, Matteo Lambertini, Giovanni Luigi Pappagallo
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel. Cancers 14 (4) (2022)
Ottavia De Simoni, Melania Scarpa, Caterina Soldà, Francesca Bergamo, Sara Lonardi, Alberto Fantin, Pierluigi Pilati, Mario Gruppo
Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (3) (2022)
Giovanni Randon, Giulia Maddalena, Marco Maria Germani, Chiara Carlotta Pircher, Francesco Pantano, Francesca Bergamo, Mirella Giordano, Caterina Sposetti, Aldo Montagna, Guglielmo Vetere, Luca Zambelli, Cosimo Rasola, Alessandra Boccaccino, Filippo Pagani, Margherita Ambrosini, Marco Massafra, Gabriella Fontanini, Massimo Milione, Matteo Fassan, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio
Negative Ultraselection of Patients With RAS / BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy. JCO precision oncology 6 (2022)
Elena Elez Fernandez, Javier Ros, Jose Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Carlota Arenillas, Kinga Bernatowicz, Raquel Comas, Shanshan Li, David Philip Kodack, Roberta Fasani, Ariadna Garcia, Javier Gonzalo-Ruiz, Alejandro Piris-Gimenez, Paolo G Nuciforo, Grainne Kerr, Rossana Intini, Aldo Montagna, Marco Maria Germani, Giovanni Randon, Ana Vivancos, Ron Smits, Diana Graus, Raquel Perez-Lopez, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Rodrigo Dienstmann, Josep Tabernero, Rodrigo A Toledo
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF<sup>V600E</sup> metastatic colorectal cancer. Nature medicine 28 (10) (2022)
Antonella Brunello, Antonella Galiano, Stefania Schiavon, Mariateresa Nardi, Alessandra Feltrin, Ardi Pambuku, Chiara De Toni, Alice Dal Col, Evelina Lamberti, Chiara Pittarello, Francesca Bergamo, Umberto Basso, Marco Maruzzo, Silvia Finotto, Maital Bolshinsky, Silvia Stragliotto, Letizia Procaccio, Mario Domenico Rizzato, Fabio Formaglio, Giuseppe Lombardi, Sara Lonardi, Vittorina Zagonel
Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy. Cancers 14 (10) (2022)
Federica Morano, Alessandra Raimondi, Filippo Pagani, Sara Lonardi, Lisa Salvatore, Chiara Cremolini, Sabina Murgioni, Giovanni Randon, Federica Palermo, Lorenzo Antonuzzo, Nicoletta Pella, Patrizia Racca, Michele Prisciandaro, Monica Niger, Francesca Corti, Francesca Bergamo, Alberto Zaniboni, Margherita Ratti, Michele Palazzo, Celeste Cagnazzo, Maria Alessandra Calegari, Federica Marmorino, Iolanda Capone, Elena Conca, Adele Busico, Silvia Brich, Elena Tamborini, Federica Perrone, Massimo Di Maio, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud, Filippo Pietrantonio
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O 6 -Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi, Marina Macchini, Mariacristina Di Marco, Guido Giordano, Enrico Vasile, Mario Scartozzi, Silvia Bozzarelli, Silvia Noventa, Maria Grazia Rodriquenz, Anna Maria Militello, Ilario Giovanni Rapposelli, Ingrid Garajovà, Stefania De Lorenzo, Barbara Merelli, Alessandro Bittoni, Lisa Salvatore, Letizia Procaccio, Chiara Paratore, Andrea Spallanzani, Umberto Peretti, Monica Niger, Elisa Giommoni, Ilaria Bernardini, Emiliano Tamburini, Katia Bernardino, Laura Forti, Maria Maddalena Valente, Stefano Cascinu, Michele Milella, Michele Reni
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). British journal of cancer (2022)
Valli De Re, Lara Alessandrini, Giulia Brisotto, Laura Caggiari, Mariangela De Zorzi, Mariateresa Casarotto, Gianmaria Miolo, Fabio Puglisi, Silvio Ken Garattini, Sara Lonardi, Renato Cannizzaro, Vincenzo Canzonieri, Angelo Paolo Dei Tos, Agostino Steffan
HER2-CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric Adenocarcinoma. Cancers 14 (5) (2022)
Andrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, Benedetta Mussolin, Francesco Rua, Giovanni Crisafulli, Alice Bartolini, Elisabetta Fenocchio, Alessio Amatu, Paolo Manca, Francesca Bergamo, Federica Tosi, Gianluca Mauri, Margherita Ambrosini, Francesca Daniel, Valter Torri, Angelo Vanzulli, Daniele Regge, Giovanni Cappello, Caterina Marchiò, Enrico Berrino, Anna Sapino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial. Nature medicine 28 (8) (2022)
Giovanni Fucà, Romain Cohen, Sara Lonardi, Kohei Shitara, Maria Elena Elez, Marwan Fakih, Joseph Chao, Samuel J Klempner, Matthew Emmett, Priya Jayachandran, Francesca Bergamo, Marc Díez García, Giacomo Mazzoli, Leonardo Provenzano, Raphael Colle, Magali Svrcek, Margherita Ambrosini, Giovanni Randon, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Keigo Chida, Akihito Kawazoe, Veronica Conca, Giuseppe Curigliano, Francesca Corti, Chiara Cremolini, Michael Overman, Thierry André, Filippo Pietrantonio
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers. Journal for immunotherapy of cancer 10 (2) (2022)
Filippo Pietrantonio, Sara Lonardi, Francesca Corti, Gabriele Infante, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Giuseppe Curigliano, Chiara Cremolini, Margherita Ambrosini, Javier Ros, Rossana Intini, Floriana Nappo, Silvia Damian, Federica Morano, Giovanni Fucà, Michael Overman, Rosalba Miceli
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (8) (2022)
Chiara Lestuzzi, Davide Stolfo, Antonino De Paoli, Alberto Banzato, Angela Buonadonna, Ettore Bidoli, Lucia Tartuferi, Elda Viel, Giulia De Angelis, Sara Lonardi, Roberto Innocente, Massimiliano Berretta, Francesca Bergamo, Alessandra Guglielmi, Gianfranco Sinagra, Joerg Herrmann
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise. The oncologist 27 (2) (2022)
Francesco Enrico D'Amico, Claudia Mescoli, Silvia Caregari, Alessio Pasquale, Ilaria Billato, Remo Alessandris, Jacopo Lanari, Domenico Bassi, Riccardo Boetto, Francesco D'Amico, Alessandro Vitale, Sara Lonardi, Enrico Gringeri, Umberto Cillo
Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma. Cancers 14 (7) (2022)
Mario Caccese, Silvia Imbevaro, Alessandra Feltrin, Daniela Costardi, Nadia Giordano, Maristella Maran, Rosalba Martino, Ketti Ottolitri, Malihe Shams, Federica Vascon, Anna Roma, Antonella Galiano, Marco Maruzzo, Dario Marino, Giuseppe Lombardi, Sara Lonardi, Antonella Brunello, Vittorina Zagonel
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology. Patient preference and adherence 16 (2022)
Alberto Fantin, Mario Gruppo, Ottavia De Simoni, Sara Lonardi, Chiara Cristofori, Tiziana Morbin, Giulia Peserico, Sabina Grillo, Annalisa Masier, Monica Franco, Pierluigi Pilati, Stefano Guzzinati, Manuel Zorzi, Massimo Rugge
Impact of Microscopic Confirmation on Therapeutic Management of Pancreatic Cancer Patients: Lessons from an Italian Regional Tumor Registry. Cancers 14 (21) (2022)
Sara Lonardi, Halla Nimeiri, Chang Xu, Daniel R Zollinger, Russell W Madison, Alexander D Fine, Ole Gjoerup, Cosimo Rasola, Valentina Angerilli, Shruti Sharma, Hsin-Ta Wu, Charuta C Palsuledesai, Meenakshi Malhotra, Alexey Aleshin, Fotios Loupakis, Elise Renkonen, Priti Hegde, Angelo Paolo Dei Tos
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection. International journal of molecular sciences 23 (19) (2022)
Roberto Moretto, Andrew Elliott, Daniele Rossini, Rossana Intini, Veronica Conca, Filippo Pietrantonio, Andrea Sartore-Bianchi, Carlotta Antoniotti, Cosimo Rasola, Mario Scartozzi, Massimiliano Salati, Nicoletta Pella, Maria Alessandra Calegari, Martina Carullo, Francesca Corti, Gianluca Mauri, Angelo Paolo Dei Tos, Gianluca Masi, Pavel Brodskiy, Heinz-Josef Lenz, Anthony Shields, Sara Lonardi, Michael Korn, Chiara Cremolini
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? British journal of cancer 127 (5) (2022)
Anna Maria Rachiglio, Laura Forgione, Raffaella Pasquale, Carlo Antonio Barone, Evaristo Maiello, Lorenzo Antonuzzo, Antonino Cassata, Giuseppe Tonini, Roberto Bordonaro, Gerardo Rosati, Alberto Zaniboni, Sara Lonardi, Daris Ferrari, Giovanni Luca Frassineti, Stefano Tamberi, Salvatore Pisconti, Francesca Di Fabio, Cristin Roma, Armando Orlandi, Tiziana Latiano, Angela Damato, Giampaolo Tortora, Carmine Pinto, Nicola Normanno
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies. Cancers 14 (4) (2022)
Letizia Procaccio, Francesca Bergamo, Francesca Daniel, Cosimo Rasola, Giada Munari, Paola Biason, Stefania Crucitta, Giulia Barsotti, Giulia Zanella, Valentina Angerilli, Cristina Magro, Silvia Paccagnella, Veronica Di Antonio, Fotios Loupakis, Romano Danesi, Vittorina Zagonel, Marzia Del Re, Sara Lonardi, Matteo Fassan
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study. Cancers 13 (20) (2021)
Antonio Pellino, Stefano Brignola, Erika Riello, Monia Niero, Sabina Murgioni, Maria Guido, Floriana Nappo, Gianluca Businello, Marta Sbaraglia, Francesca Bergamo, Gaya Spolverato, Salvatore Pucciarelli, Stefano Merigliano, Pierluigi Pilati, Francesco Cavallin, Stefano Realdon, Fabio Farinati, Angelo Paolo Dei Tos, Vittorina Zagonel, Sara Lonardi, Fotios Loupakis, Angelo Paolo Dei Tos
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas. Journal of personalized medicine 11 (11) (2021)
Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino, Ioannis Souglakos, Fang-Shu Ou, Jeffrey P Meyers, Qian Shi, Axel Grothey, Mark P Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Hollander, Fabio Galli, Kentaro Yamazaki, Vassilis Georgoulias, Rachel Kerr, Eiji Oki, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2021)
Elisa Fontana, Jeff Meyers, Alberto F Sobrero, Timothy J Iveson, Anthony F Shields, Gilles Manceau, Takayuki Yoshino, Ioannis Souglakos, Elizabeth C Smyth, Florian Lordick, Markus Möhler, Anne Giraut, Andrea Harkin, Roberto Labianca, Jeffrey Meyerhardt, Thierry André, Ioannis Boukovinas, Sara Lonardi, Mark Saunders, Dewi Vernerey, Eiji Oki, Vassilis Georgoulias, Irit Ben-Aharon, Qian Shi
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
J Randolph Hecht, Sara Lonardi, Johanna Bendell, Hao-Wen Sim, Teresa Macarulla, Charles D Lopez, Eric Van Cutsem, Andrés Muñoz Martin, Joon Oh Park, Richard Greil, Hong Wang, Rebecca R Hozak, Ivelina Gueorguieva, Yong Lin, Sujata Rao, Baek-Yeol Ryoo
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Heinz-Josef Lenz, Eric Van Cutsem, Maria Luisa Limon, Ka Yeung Mark Wong, Alain Hendlisz, Massimo Aglietta, Pilar García-Alfonso, Bart Neyns, Gabriele Luppi, Dana Backlund Cardin, Tomislav Dragovich, Usman Shah, Sandzhar Abdullaev, Joseph Gricar, Jean-Marie Ledeine, Michael James Overman, Sara Lonardi
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Valentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, Fabio Marra, Sara Lonardi, Emiliano Tamburini, Piscaglia Fabio, Gianluca Masi, Ciro Celsa, Francesco Giuseppe Foschi, Marianna Silletta, Daniela Caterina Amoruso, Margherita Rimini, Mariangela Bruccoleri, Raffaella Tortora, Claudia Campani, Caterina Soldà, Massimo Giuseppe Viola, Antonella Forgione, Fabio Conti, Francesca Salani, Silvia Catanese, Carmelo Marco Giacchetto, Claudia Fulgenzi, Carmine Coppola, Pietro Lampertico, Antonio Pellino, Gabriele Rancatore, Giuseppe Cabibbo, Francesca Ratti, Federica Pedica, Angelo Della Corte, Massimo Colombo, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Stefano Cascinu
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy. Cancer management and research 13 (2021)
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, Wu Zhang, Chiara Cremolini, Sara Lonardi, Satoshi Okazaki, Martin D Berger, Yuji Miyamoto, Shivani Soni, Afsaneh Barzi, Toshiharu Yamaguchi, Fotios Loupakis, Alfredo Falcone, Heinz-Josef Lenz
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer. The pharmacogenomics journal 21 (3) (2021)
Roberto Moretto, Daniele Rossini, Veronica Conca, Sara Lonardi, Cosimo Rasola, Carlotta Antoniotti, Daniele Santini, Federica Marmorino, Gianluca Tomasello, Beatrice Borelli, Salvatore Caponnetto, Gemma Zucchelli, Alberto Zaniboni, Margherita Ambrosini, Angela Buonadonna, Laura Fanchini, Samanta Cupini, Gianluca Masi, Alfredo Falcone, Chiara Cremolini
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies. British journal of cancer 125 (6) (2021)
Sara Lonardi, Alessandra Anna Prete, Federica Morano, Marco Messina, Vincenzo Formica, Domenico Cristiano Corsi, Corrado Orciuolo, Giovanni Luca Frassineti, Maria Giulia Zampino, Mariaelena Casagrande, Gianluca Masi, Monica Ronzoni, Mario Scartozzi, Angela Buonadonna, Stefania Mosconi, Margherita Ratti, Andrea Sartore-Bianchi, Emiliano Tamburini, Michele Prisciandaro, Francesca Bergamo, Massimiliano Spada, Salvatore Corallo, Valentina Vettore, Fotios Loupakis, Matteo Fassan, Paola Del Bianco, Vittorina Zagonel, Filippo Pietrantonio
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study. Journal for immunotherapy of cancer 9 (11) (2021)
Francesco Graziano, Nicholas W Fischer, Irene Bagaloni, Maria Di Bartolomeo, Sara Lonardi, Bruno Vincenzi, Giuseppe Perrone, Lorenzo Fornaro, Elena Ongaro, Giuseppe Aprile, Renato Bisonni, Michele Prisciandaro, David Malkin, Jean Gariépy, Angelo Paolo Dei Tos, Fotios Loupakis, Donatella Sarti, Michela Del Prete, Vincenzo Catalano, Paolo Alessandroni, Mauro Magnani, Annamaria Ruzzo
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy. Cancers 12 (8) (2020)
Mitsukuni Suenaga, Marta Schirripa, Shu Cao, Wu Zhang, Dongyun Yang, Chiara Cremolini, Sabina Murgioni, Sara Lonardi, Yan Ning, Satoshi Okazaki, Martin D Berger, Yuji Miyamoto, Afsaneh Barzi, Fotios Loupakis, Alfredo Falcone, Heinz-Josef Lenz
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial. Cancers 12 (7) (2020)
Romain Cohen, Gilles Manceau, Jack Fiskum, Greg Yothers, Richard M Goldberg, Takayuki Yoshino, Steven R Alberts, Carmen Allegra, Aimery de Gramont, Jean-Francois Seitz, Michael O'Connell, Daniel Haller, Norman Wolmark, Charles Erlichman, Alberto Zaniboni, Sara Lonardi, Rachel Kerr, Axel Grothey, Frank A Sinicrope, Thierry André, Qian Shi
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2020)
Markus Möhler, Mikhail Dvorkin, Narikazu Boku, Mustafa Özgüroğlu, Min-Hee Ryu, Alina S Muntean, Sara Lonardi, Marina Nechaeva, Arinilda C Bragagnoli, Hasan S Coşkun, Antonio Cubillo Gracian, Toshimi Takano, Rachel Wong, Howard Safran, Gina M Vaccaro, Zev A Wainberg, Matthew R Silver, Huiling Xiong, Janet Hong, Gilles Manceau, Yung-Jue Bang
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2020)
Riccardo Giampieri, Pina Ziranu, Bruno Daniele, Antonio Zizzi, Daris Ferrari, Sara Lonardi, Alberto Zaniboni, Luigi Cavanna, Gerardo Rosati, Mariaelena Casagrande, Nicoletta Pella, Laura Demurtas, Maria Giulia Zampino, Pietro Sozzi, Valeria Pusceddu, Domenico Germano, Eleonora Lai, Vittorina Zagonel, Carla Codecà, Michela Libertini, Marco Puzzoni, Roberto Labianca, Stefano Cascinu, Mario Scartozzi
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy. Cancers 12 (5) (2020)
Letizia Procaccio, Marta Schirripa, Matteo Fassan, Loredana Vecchione, Francesca Bergamo, Alessandra Anna Prete, Rossana Intini, Chiara Manai, Vincenzo Dadduzio, Alice Boscolo, Vittorina Zagonel, Sara Lonardi
Immunotherapy in Gastrointestinal Cancers. BioMed research international 2017 (2017)